What does Hexafar do?
HEXAFAR is a company specializing in the development and production of innovative pharmaceutical products. It focuses on delivering high-quality solutions to meet the needs of healthcare professionals and patients. The company is committed to research and development to advance therapeutic options in various medical fields.
- Sectors
- Lawyers
- Activities
- Signals
-
ProfitableProfitable € 72K
The company reported a positive net result in the latest financial year.
Strong equityStrong equity € 1.70MStrong equity provides a buffer against setbacks.
Low riskLow risk 86.7%Good solvency (> 30%) points to long-term financial stability.
Good liquidityGood liquidity 7.50A healthy current ratio (≥ 1.5): enough current assets to cover short-term debt.
Positive cashflowPositive cashflow € 109KPositive operating cash flow in the latest financial year.
Positive EBITDAPositive EBITDA € 120KPositive EBITDA: operating activities are profitable.
Financial ratios
|
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2025
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2024
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2023
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2022
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
|---|---|---|---|---|
|
€
130K
|
€
129K
|
€
133K
|
€
116K
|
|
|
€
120K
|
€
119K
|
€
124K
|
€
114K
|
|
|
€
72K
|
€
88K
|
€
93K
|
€
41K
|
|
|
€
1.70M
|
€
1.63M
|
€
1.54M
|
€
1.45M
|
|
|
86.74%
|
84.34%
|
82.31%
|
80.19%
|
|
|
€
260K
|
€
303K
|
€
331K
|
€
358K
|
|
|
€
947K
|
€
876K
|
€
777K
|
€
679K
|
Publications 11
All publications- Statuten (Vertaling, Cordinatie, Overige Wijzigingen, ) - Wijziging Rechtsvorm - Doel - Ontslagen - Benoemingen 28/07/2021
- Me. - Jaarrekening 31.12.2015, Ggk 06.07.2016, Ngl 18.07.2016 16324-0157-012 22/07/2016
- Me. - Jaarrekening 31.12.2014, Ggk 05.08.2015, Ngl 24.08.2015 15453-0409-012 26/08/2015
- Me. - Jaarrekening 31.12.2013, Ggk 06.08.2014, Ngl 25.08.2014 14466-0135-012 28/08/2014
- Kapitaal - Aandelen - Statuten (Vertaling, Cordinatie, Overige Wijzigingen, ) 07/05/2014
Frequently asked questions
Answers to the most common questions about Hexafar, based on official government data and the filed annual accounts.
What is the VAT number of Hexafar?
The VAT number of Hexafar is BE0810.007.705.
When was Hexafar established?
Hexafar was founded in 24-02-2009.
What is the official address of Hexafar?
The official address of Hexafar is Gentstraat 127 Oudenaarde 9700.
What is the legal form of Hexafar?
The juridical form of Hexafar is Private limited company (BV/SRL).
What is the annual revenue of Hexafar?
The 2025 accounts of Hexafar do not report revenue. Smaller companies that file abbreviated accounts are not required to publish it.
What does Hexafar do?
HEXAFAR is a company specializing in the development and production of innovative pharmaceutical products. It focuses on delivering high-quality solutions to meet the needs of healthcare professionals and patients. The company is committed to research and development to advance therapeutic options in various medical fields.
Is Hexafar a reliable company?
Hexafar is a registered Rechtspersoon with company number 0810.007.705 and can be verified through the official CBE database.
What is the credit limit of Hexafar?
The estimated credit limit of Hexafar is €200,127.
Is Hexafar still active?
Hexafar currently has the status "Normal situation" and is active.